Intro

This chapter reviews recent advancements in chronic lymphocytic leukemia (CLL) management, highlighting new therapies like BTK inhibitors and venetoclax. The speakers also compare these modern treatments to traditional methods and discuss their impact on patient survival and quality of life.

Transcript

Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.